Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis

Associations between the use of aspirin or other antiplatelet drugs and all-cause mortality among patients with COVID-19: A meta-analysis

Introduction: Whether aspirin or other antiplatelet drugs can reduce mortality among patients with coronavirus disease (COVID-19) remains controversial.Methods: We identified randomized controlled trials, prospective cohort studies, and retrospective studies on associations between aspirin or other...

Full description

Bibliographic Details
Main Authors: Wanting Su, He Miao, Zhaotian Guo, Qianhui Chen, Tao Huang, Renyu Ding
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Pharmacology
Subjects:
aspirin
antiplatelet drug
mortality
COVID-19
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2022.989903/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2022.989903/full

Similar Items